Genetic testing for long-qt syndrome: Distinguishing pathogenic mutations from benign variants

Suraj Kapa, David J. Tester, Benjamin A. Salisbury, Carole Harris-Kerr, Manish S. Pungliya, Marielle Alders, Arthur A M Wilde, Michael John Ackerman

Research output: Contribution to journalArticle

240 Citations (Scopus)

Abstract

BACKGROUND-: Genetic testing for long-QT syndrome (LQTS) has diagnostic, prognostic, and therapeutic implications. Hundreds of causative mutations in 12 known LQTS-susceptibility genes have been identified. Genetic testing that includes the 3 most commonly mutated genes is available clinically. Distinguishing pathogenic mutations from innocuous rare variants is critical to the interpretation of test results. We sought to quantify the value of mutation type and gene/protein region in determining the probability of pathogenicity for mutations. METHODS AND RESULTS-: Type, frequency, and location of mutations across KCNQ1 (LQT1), KCNH2 (LQT2), and SCN5A (LQT3) were compared between 388 unrelated "definite" (clinical diagnostic score ≥4 and/or QTc ≥480 ms) cases of LQTS and >1300 healthy controls for each gene. From these data, estimated predictive values (percent of mutations found in definite cases that would cause LQTS) were determined according to mutation type and location. Mutations were 10 times more common in cases than controls (0.58 per case versus 0.06 per control). Missense mutations were the most common, accounting for 78%, 67%, and 89% of mutations in KCNQ1, KCNH2, and SCN5A in cases and >95% in controls. Nonmissense mutations have an estimated predictive value >99% regardless of location. In contrast, location appears to be critical for characterizing missense mutations. Relative frequency of missense mutations between cases and controls ranged from ≈1:1 in the SCN5A interdomain linker to infinity in the pore, transmembrane, and linker in KCNH2. These correspond to estimated predictive values ranging from 0% in the interdomain linker of SCN5A to 100% in the transmembrane/linker/pore regions of KCNH2. The estimated predictive value is also high in the linker, pore, transmembrane, and C terminus of KCNQ1 and the transmembrane/linker of SCN5A. CONCLUSIONS-: Distinguishing pathogenic mutations from rare variants is of critical importance in the interpretation of genetic testing in LQTS. Mutation type, mutation location, and ethnic-specific background rates are critical factors in predicting the pathogenicity of novel mutations. Novel mutations in low-estimated predictive value regions such as the interdomain linker of SCN5A should be viewed as variants of uncertain significance and prompt further investigation to clarify the likelihood of disease causation. However, mutations in regions such as the transmembrane, linker, and pore of KCNQ1 and KCNH2 may be defined confidently as high-probability LQTS-causing mutations. These findings will have implications for other genetic disorders involving mutational analysis.

Original languageEnglish (US)
Pages (from-to)1752-1760
Number of pages9
JournalCirculation
Volume120
Issue number18
DOIs
StatePublished - Nov 2009

Fingerprint

Genetic Testing
Mutation
Long QT Syndrome
Missense Mutation
Virulence
Genes
Inborn Genetic Diseases
Mutation Rate
Causality

Keywords

  • Genetic testing
  • Genetics
  • Ion channels
  • Long-QT syndrome
  • Mutations

ASJC Scopus subject areas

  • Physiology (medical)
  • Cardiology and Cardiovascular Medicine

Cite this

Genetic testing for long-qt syndrome : Distinguishing pathogenic mutations from benign variants. / Kapa, Suraj; Tester, David J.; Salisbury, Benjamin A.; Harris-Kerr, Carole; Pungliya, Manish S.; Alders, Marielle; Wilde, Arthur A M; Ackerman, Michael John.

In: Circulation, Vol. 120, No. 18, 11.2009, p. 1752-1760.

Research output: Contribution to journalArticle

Kapa, S, Tester, DJ, Salisbury, BA, Harris-Kerr, C, Pungliya, MS, Alders, M, Wilde, AAM & Ackerman, MJ 2009, 'Genetic testing for long-qt syndrome: Distinguishing pathogenic mutations from benign variants', Circulation, vol. 120, no. 18, pp. 1752-1760. https://doi.org/10.1161/CIRCULATIONAHA.109.863076
Kapa, Suraj ; Tester, David J. ; Salisbury, Benjamin A. ; Harris-Kerr, Carole ; Pungliya, Manish S. ; Alders, Marielle ; Wilde, Arthur A M ; Ackerman, Michael John. / Genetic testing for long-qt syndrome : Distinguishing pathogenic mutations from benign variants. In: Circulation. 2009 ; Vol. 120, No. 18. pp. 1752-1760.
@article{6f86dd7bd7a1473399640e7110e596e5,
title = "Genetic testing for long-qt syndrome: Distinguishing pathogenic mutations from benign variants",
abstract = "BACKGROUND-: Genetic testing for long-QT syndrome (LQTS) has diagnostic, prognostic, and therapeutic implications. Hundreds of causative mutations in 12 known LQTS-susceptibility genes have been identified. Genetic testing that includes the 3 most commonly mutated genes is available clinically. Distinguishing pathogenic mutations from innocuous rare variants is critical to the interpretation of test results. We sought to quantify the value of mutation type and gene/protein region in determining the probability of pathogenicity for mutations. METHODS AND RESULTS-: Type, frequency, and location of mutations across KCNQ1 (LQT1), KCNH2 (LQT2), and SCN5A (LQT3) were compared between 388 unrelated {"}definite{"} (clinical diagnostic score ≥4 and/or QTc ≥480 ms) cases of LQTS and >1300 healthy controls for each gene. From these data, estimated predictive values (percent of mutations found in definite cases that would cause LQTS) were determined according to mutation type and location. Mutations were 10 times more common in cases than controls (0.58 per case versus 0.06 per control). Missense mutations were the most common, accounting for 78{\%}, 67{\%}, and 89{\%} of mutations in KCNQ1, KCNH2, and SCN5A in cases and >95{\%} in controls. Nonmissense mutations have an estimated predictive value >99{\%} regardless of location. In contrast, location appears to be critical for characterizing missense mutations. Relative frequency of missense mutations between cases and controls ranged from ≈1:1 in the SCN5A interdomain linker to infinity in the pore, transmembrane, and linker in KCNH2. These correspond to estimated predictive values ranging from 0{\%} in the interdomain linker of SCN5A to 100{\%} in the transmembrane/linker/pore regions of KCNH2. The estimated predictive value is also high in the linker, pore, transmembrane, and C terminus of KCNQ1 and the transmembrane/linker of SCN5A. CONCLUSIONS-: Distinguishing pathogenic mutations from rare variants is of critical importance in the interpretation of genetic testing in LQTS. Mutation type, mutation location, and ethnic-specific background rates are critical factors in predicting the pathogenicity of novel mutations. Novel mutations in low-estimated predictive value regions such as the interdomain linker of SCN5A should be viewed as variants of uncertain significance and prompt further investigation to clarify the likelihood of disease causation. However, mutations in regions such as the transmembrane, linker, and pore of KCNQ1 and KCNH2 may be defined confidently as high-probability LQTS-causing mutations. These findings will have implications for other genetic disorders involving mutational analysis.",
keywords = "Genetic testing, Genetics, Ion channels, Long-QT syndrome, Mutations",
author = "Suraj Kapa and Tester, {David J.} and Salisbury, {Benjamin A.} and Carole Harris-Kerr and Pungliya, {Manish S.} and Marielle Alders and Wilde, {Arthur A M} and Ackerman, {Michael John}",
year = "2009",
month = "11",
doi = "10.1161/CIRCULATIONAHA.109.863076",
language = "English (US)",
volume = "120",
pages = "1752--1760",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "18",

}

TY - JOUR

T1 - Genetic testing for long-qt syndrome

T2 - Distinguishing pathogenic mutations from benign variants

AU - Kapa, Suraj

AU - Tester, David J.

AU - Salisbury, Benjamin A.

AU - Harris-Kerr, Carole

AU - Pungliya, Manish S.

AU - Alders, Marielle

AU - Wilde, Arthur A M

AU - Ackerman, Michael John

PY - 2009/11

Y1 - 2009/11

N2 - BACKGROUND-: Genetic testing for long-QT syndrome (LQTS) has diagnostic, prognostic, and therapeutic implications. Hundreds of causative mutations in 12 known LQTS-susceptibility genes have been identified. Genetic testing that includes the 3 most commonly mutated genes is available clinically. Distinguishing pathogenic mutations from innocuous rare variants is critical to the interpretation of test results. We sought to quantify the value of mutation type and gene/protein region in determining the probability of pathogenicity for mutations. METHODS AND RESULTS-: Type, frequency, and location of mutations across KCNQ1 (LQT1), KCNH2 (LQT2), and SCN5A (LQT3) were compared between 388 unrelated "definite" (clinical diagnostic score ≥4 and/or QTc ≥480 ms) cases of LQTS and >1300 healthy controls for each gene. From these data, estimated predictive values (percent of mutations found in definite cases that would cause LQTS) were determined according to mutation type and location. Mutations were 10 times more common in cases than controls (0.58 per case versus 0.06 per control). Missense mutations were the most common, accounting for 78%, 67%, and 89% of mutations in KCNQ1, KCNH2, and SCN5A in cases and >95% in controls. Nonmissense mutations have an estimated predictive value >99% regardless of location. In contrast, location appears to be critical for characterizing missense mutations. Relative frequency of missense mutations between cases and controls ranged from ≈1:1 in the SCN5A interdomain linker to infinity in the pore, transmembrane, and linker in KCNH2. These correspond to estimated predictive values ranging from 0% in the interdomain linker of SCN5A to 100% in the transmembrane/linker/pore regions of KCNH2. The estimated predictive value is also high in the linker, pore, transmembrane, and C terminus of KCNQ1 and the transmembrane/linker of SCN5A. CONCLUSIONS-: Distinguishing pathogenic mutations from rare variants is of critical importance in the interpretation of genetic testing in LQTS. Mutation type, mutation location, and ethnic-specific background rates are critical factors in predicting the pathogenicity of novel mutations. Novel mutations in low-estimated predictive value regions such as the interdomain linker of SCN5A should be viewed as variants of uncertain significance and prompt further investigation to clarify the likelihood of disease causation. However, mutations in regions such as the transmembrane, linker, and pore of KCNQ1 and KCNH2 may be defined confidently as high-probability LQTS-causing mutations. These findings will have implications for other genetic disorders involving mutational analysis.

AB - BACKGROUND-: Genetic testing for long-QT syndrome (LQTS) has diagnostic, prognostic, and therapeutic implications. Hundreds of causative mutations in 12 known LQTS-susceptibility genes have been identified. Genetic testing that includes the 3 most commonly mutated genes is available clinically. Distinguishing pathogenic mutations from innocuous rare variants is critical to the interpretation of test results. We sought to quantify the value of mutation type and gene/protein region in determining the probability of pathogenicity for mutations. METHODS AND RESULTS-: Type, frequency, and location of mutations across KCNQ1 (LQT1), KCNH2 (LQT2), and SCN5A (LQT3) were compared between 388 unrelated "definite" (clinical diagnostic score ≥4 and/or QTc ≥480 ms) cases of LQTS and >1300 healthy controls for each gene. From these data, estimated predictive values (percent of mutations found in definite cases that would cause LQTS) were determined according to mutation type and location. Mutations were 10 times more common in cases than controls (0.58 per case versus 0.06 per control). Missense mutations were the most common, accounting for 78%, 67%, and 89% of mutations in KCNQ1, KCNH2, and SCN5A in cases and >95% in controls. Nonmissense mutations have an estimated predictive value >99% regardless of location. In contrast, location appears to be critical for characterizing missense mutations. Relative frequency of missense mutations between cases and controls ranged from ≈1:1 in the SCN5A interdomain linker to infinity in the pore, transmembrane, and linker in KCNH2. These correspond to estimated predictive values ranging from 0% in the interdomain linker of SCN5A to 100% in the transmembrane/linker/pore regions of KCNH2. The estimated predictive value is also high in the linker, pore, transmembrane, and C terminus of KCNQ1 and the transmembrane/linker of SCN5A. CONCLUSIONS-: Distinguishing pathogenic mutations from rare variants is of critical importance in the interpretation of genetic testing in LQTS. Mutation type, mutation location, and ethnic-specific background rates are critical factors in predicting the pathogenicity of novel mutations. Novel mutations in low-estimated predictive value regions such as the interdomain linker of SCN5A should be viewed as variants of uncertain significance and prompt further investigation to clarify the likelihood of disease causation. However, mutations in regions such as the transmembrane, linker, and pore of KCNQ1 and KCNH2 may be defined confidently as high-probability LQTS-causing mutations. These findings will have implications for other genetic disorders involving mutational analysis.

KW - Genetic testing

KW - Genetics

KW - Ion channels

KW - Long-QT syndrome

KW - Mutations

UR - http://www.scopus.com/inward/record.url?scp=70449359365&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70449359365&partnerID=8YFLogxK

U2 - 10.1161/CIRCULATIONAHA.109.863076

DO - 10.1161/CIRCULATIONAHA.109.863076

M3 - Article

C2 - 19841300

AN - SCOPUS:70449359365

VL - 120

SP - 1752

EP - 1760

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 18

ER -